Regulatory Compliance, Shipping Services 7 Jan 2025 regulatory compliance, business operations, postal service, negotiated service agreements, shipping

📦Notice of Postal Service Product Change for Business Shipping Options

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

Learn More
Regulatory Change, Business Strategy 7 Jan 2025 regulatory compliance, postal service, shipping, usps, business contracts

📦USPS Notice of Product Change for Priority Mail and Ground Advantage

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

Learn More
Compliance, Regulatory 7 Jan 2025 regulatory compliance, federal reserve, financial services, bank control, business acquisitions
Regulatory Compliance, Infrastructure Development 7 Jan 2025 environmental impact, aviation, procurement, defense, military

✈️Decision Notice for Air National Guard Environmental Impact Statement

On December 19, 2024, the Department of the Air Force (DAF) signed the Record of Decision (ROD) for the Air National Guard F-15EX Eagle II & F-35A Lightning II Operational Beddowns Environmental Impact Statement.

Learn More
Regulatory Compliance, Trade Agreements 7 Jan 2025 international trade, antidumping duty, trade regulations, usitc, solar panels

☀️USITC Investigation on Crystalline Silicon Photovoltaic Products

The Commission hereby gives notice of the scheduling of the final phase of antidumping and countervailing duty investigation Nos. 701-TA-722-725 and 731-TA-1690-1693 (Final) pursuant to the Tariff Act of 1930 ("the Act") to determine whether an industry in the United States is materially injured or threatened with material injury, or the establishment of an industry in the United States is materially retarded, by reason of imports of crystalline silicon photovoltaic products (solar panels) from Cambodia, Malaysia, Thailand, and Vietnam, provided for in statistical reporting numbers 8541.42.0010 and 8541.43.0010 of the Harmonized Tariff Schedule of the United States. Crystalline silicon photovoltaic cells, whether or not assemabled into modules, may also be imported under subheadings 8501.71, 8501.72, and 8501.80 and statistical reporting number 8507.20.8010, preliminarily determined by the Department of Commerce ("Commerce") to be subsidized and sold at less-than-fair-value.

Learn More
Regulatory Compliance, Industry Guidance 7 Jan 2025 regulatory compliance, fda guidance, ingredient consultation, animal food, safety assessment

🐾FDA's Guidance on Animal Food Ingredient Consultation Released

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry #294 entitled "Animal Food Ingredient Consultation (AFIC)." This guidance describes FDA's interim AFIC process and explains one way FDA will work with firms that are developing animal food ingredients now that the Memorandum of Understanding (MOU) with the Association of American Feed Control Officials (AAFCO) expired on October 1, 2024, and while FDA evaluates the animal Food Additive Petition and Generally Recognized as Safe (GRAS) Notification programs. The AFIC process provides an additional way for engagement with FDA regarding ingredients for which firms may otherwise have used the AAFCO ingredient definition process. AFIC will help FDA identify any potential safety concerns associated with such ingredients. The AFIC process also allows for public awareness of and input on such ingredients. In addition, this guidance describes FDA's enforcement policy for certain ingredients assessed using the AFIC process.

Learn More
Compliance, Infrastructure Development 7 Jan 2025 compliance, alaska, marine mammals, incidental take, construction regulations

🌊Incidental Take Authorization for Hoonah Cargo Dock Project

NMFS has received a request from the City of Hoonah (Hoonah) for authorization to take marine mammals incidental to pile driving and removal activities associated with the Hoonah Cargo Dock project in Hoonah, Alaska. Pursuant to the Marine Mammal Protection Act (MMPA), NMFS is requesting comments on its proposal to issue an incidental harassment authorization (IHA) to incidentally take marine mammals during the specified activities. NMFS is also requesting comments on a possible one-time, 1-year renewal that could be issued under certain circumstances and if all requirements are met. NMFS will consider public comments prior to making any final decision on the issuance of the requested MMPA authorization and agency responses will be summarized in the final notice of our decision.

Learn More
Regulatory Changes, Shipping Services 7 Jan 2025 regulatory compliance, postal service, shipping, contracts, business services

📦USPS Notice on Priority Mail Express and Ground Advantage Changes

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

Learn More
Regulatory Requirements, Economic Development 7 Jan 2025 business operations, postal service, negotiated service agreements, shipping, contract changes

📦Notice of Priority Mail and USPS Ground Advantage Changes

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

Learn More
Compliance, Regulatory Guidance 7 Jan 2025 compliance, healthcare, fda, drug regulation, artificial intelligence

🤖FDA Draft Guidance on AI Use in Drug Regulation Available for Comments

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products." In accordance with its mission of protecting, promoting, and advancing public health, FDA's Center for Drug Evaluation and Research (CDER), in collaboration with the Center for Biologics Evaluation and Research (CBER), the Center for Devices and Radiological Health (CDRH), the Center for Veterinary Medicine (CVM), the Oncology Center of Excellence (OCE), the Office of Combination Products (OCP), and the Office of Inspections and Investigations (OII), is issuing this draft guidance to provide recommendations to industry on the use of artificial intelligence (AI) to produce information or data intended to support regulatory decision-making regarding the safety, effectiveness, or quality for drug and biological products.

Learn More